307 related articles for article (PubMed ID: 22626608)
1. The cost effectiveness of radiofrequency ablation for Barrett's esophagus.
Hur C; Choi SE; Rubenstein JH; Kong CY; Nishioka NS; Provenzale DT; Inadomi JM
Gastroenterology; 2012 Sep; 143(3):567-575. PubMed ID: 22626608
[TBL] [Abstract][Full Text] [Related]
2. A cost-utility analysis of ablative therapy for Barrett's esophagus.
Inadomi JM; Somsouk M; Madanick RD; Thomas JP; Shaheen NJ
Gastroenterology; 2009 Jun; 136(7):2101-2114.e1-6. PubMed ID: 19272389
[TBL] [Abstract][Full Text] [Related]
3. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis.
Kastelein F; van Olphen S; Steyerberg EW; Sikkema M; Spaander MC; Looman CW; Kuipers EJ; Siersema PD; Bruno MJ; de Bekker-Grob EW;
Gut; 2015 Jun; 64(6):864-71. PubMed ID: 25037191
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia.
Small AJ; Araujo JL; Leggett CL; Mendelson AH; Agarwalla A; Abrams JA; Lightdale CJ; Wang TC; Iyer PG; Wang KK; Rustgi AK; Ginsberg GG; Forde KA; Gimotty PA; Lewis JD; Falk GW; Bewtra M
Gastroenterology; 2015 Sep; 149(3):567-76.e3; quiz e13-4. PubMed ID: 25917785
[TBL] [Abstract][Full Text] [Related]
5. Comparative Effectiveness of Esophagectomy Versus Endoscopic Treatment for Esophageal High-grade Dysplasia.
Hu Y; Puri V; Shami VM; Stukenborg GJ; Kozower BD
Ann Surg; 2016 Apr; 263(4):719-26. PubMed ID: 26672723
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Radiofrequency Ablation versus Endoscopic Surveillance for Barrett's Esophagus with Low-Grade Dysplasia: A Systematic Review and Meta-Analysis.
Klair JS; Zafar Y; Nagra N; Murali AR; Jayaraj M; Singh D; Rustagi T; Krishnamoorthi R
Dig Dis; 2021; 39(6):561-568. PubMed ID: 33503615
[TBL] [Abstract][Full Text] [Related]
7. What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis.
Shaheen NJ; Inadomi JM; Overholt BF; Sharma P
Gut; 2004 Dec; 53(12):1736-44. PubMed ID: 15542506
[TBL] [Abstract][Full Text] [Related]
8. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Radiofrequency Ablation vs. Endoscopic Surveillance for Barrett's Esophagus With Low-Grade Dysplasia: Meta-Analysis of Randomized Controlled Trials.
Wang Y; Ma B; Yang S; Li W; Li P
Front Oncol; 2022; 12():801940. PubMed ID: 35296005
[TBL] [Abstract][Full Text] [Related]
10. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness Analysis of Radiofrequency Ablation in Patients With Barrett Esophagus and High-grade Dysplasia or Low-grade Dysplasia.
Federici C; Callea G; Testoni PA; Costamagna G; Trentino P; Repici A
Clin Ther; 2023 May; 45(5):426-436. PubMed ID: 37137786
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia.
Kahn A; Al-Qaisi M; Kommineni VT; Callaway JK; Boroff ES; Burdick GE; Lam-Himlin DM; Temkit M; Vela MF; Ramirez FC
Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29036431
[TBL] [Abstract][Full Text] [Related]
13. An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus.
Das A; Wells C; Kim HJ; Fleischer DE; Crowell MD; Sharma VK
Endoscopy; 2009 May; 41(5):400-8. PubMed ID: 19418393
[TBL] [Abstract][Full Text] [Related]
14. The cost-effectiveness of radiofrequency ablation for Barrett's esophagus with low-grade dysplasia: results from a randomized controlled trial (SURF trial).
Phoa KN; Rosmolen WD; Weusten BLAM; Bisschops R; Schoon EJ; Das S; Ragunath K; Fullarton G; DiPietro M; Ravi N; Tijssen JGP; Dijkgraaf MGW; Bergman JJGHM;
Gastrointest Endosc; 2017 Jul; 86(1):120-129.e2. PubMed ID: 27956164
[TBL] [Abstract][Full Text] [Related]
15. Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett's esophagus.
Benaglia T; Sharples LD; Fitzgerald RC; Lyratzopoulos G
Gastroenterology; 2013 Jan; 144(1):62-73.e6. PubMed ID: 23041329
[TBL] [Abstract][Full Text] [Related]
16. A cost-effectiveness analysis of endoscopic eradication therapy for management of dysplasia arising in patients with Barrett's oesophagus in the United Kingdom.
Pollit V; Graham D; Leonard C; Filby A; McMaster J; Mealing SJ; Lovat LB; Haidry RJ
Curr Med Res Opin; 2019 May; 35(5):805-815. PubMed ID: 30479169
[TBL] [Abstract][Full Text] [Related]
17. Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagus.
Titi M; Overhiser A; Ulusarac O; Falk GW; Chak A; Wang K; Sharma P
Gastroenterology; 2012 Sep; 143(3):564-566.e1. PubMed ID: 22561053
[TBL] [Abstract][Full Text] [Related]
18. Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia.
Duits LC; van der Wel MJ; Cotton CC; Phoa KN; Ten Kate FJW; Seldenrijk CA; Offerhaus GJA; Visser M; Meijer SL; Mallant-Hent RC; Krishnadath KK; Pouw RE; Tijssen JGP; Shaheen NJ; Bergman JJGHM
Gastroenterology; 2017 Apr; 152(5):993-1001.e1. PubMed ID: 28012849
[TBL] [Abstract][Full Text] [Related]
19. The case for endoscopic treatment of non-dysplastic and low-grade dysplastic Barrett's esophagus.
Fleischer DE; Odze R; Overholt BF; Carroll J; Chang KJ; Das A; Goldblum J; Miller D; Lightdale CJ; Peters J; Rothstein R; Sharma VK; Smith D; Velanovich V; Wolfsen H; Triadafilopoulos G
Dig Dis Sci; 2010 Jul; 55(7):1918-31. PubMed ID: 20405211
[TBL] [Abstract][Full Text] [Related]
20. The role of radiofrequency ablation in the management of Barrett's esophagus.
Bulsiewicz WJ; Shaheen NJ
Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):95-109. PubMed ID: 21112500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]